Immune Parameters in The Prognosis and Therapy Monitoring of Cutaneous Melanoma Patients: Experience, Role, and Limitations
Cutaneous melanoma is an immune-dependent aggressive tumour. Up to our knowledge, there are no reports regarding immune parameters monitoring in longitudinal followup of melanoma patients. We report a followup for 36 months of the immune parameters of patients diagnosed in stages I–IV. The circulato...
Main Authors: | Monica Neagu, Carolina Constantin, Sabina Zurac |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2013-01-01
|
Series: | BioMed Research International |
Online Access: | http://dx.doi.org/10.1155/2013/107940 |
Similar Items
-
Inflammatory Cytokine Pattern Is Sex-Dependent in Mouse Cutaneous Melanoma Experimental Model
by: Mihaela Surcel, et al.
Published: (2017-01-01) -
miRNAs in the Diagnosis and Prognosis of Skin Cancer
by: Monica Neagu, et al.
Published: (2020-02-01) -
Metabolic Traits in Cutaneous Melanoma
by: Monica Neagu, et al.
Published: (2020-05-01) -
Immune based therapy for melanoma
by: Robert Ancuceanu, et al.
Published: (2016-01-01) -
Interrogating Epigenome toward Personalized Approach in Cutaneous Melanoma
by: Elena-Georgiana Dobre, et al.
Published: (2021-09-01)